These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5705781)

  • 21. Chemotherapy of advanced L1210 leukemia with platinum compounds in combination with other antitumor agents.
    Gale GR; Atkins LM; Meischen SJ; Smith AB; Walker EM
    Cancer Treat Rep; 1977; 61(3):445-50. PubMed ID: 872142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.
    Griswold DP; Trader MW; Frei E; Peters WP; Wolpert MK; Laster WR
    Cancer Res; 1987 May; 47(9):2323-7. PubMed ID: 3567926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy and immunotherapy of three human lymphomas serially transplantable in the neonatal Syrian hamster.
    Adams RA; Flowers A; Sundeen R; Merk LP
    Cancer; 1972 Feb; 29(2):524-33. PubMed ID: 4501701
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthesis and biological activity of 3,5-dinitro-4- and -2-(1H-purin-6-ylthio)benzoates, prodrugs of 6-mercaptopurine.
    Drawbaugh R; Bouffard C; Strauss M
    J Med Chem; 1976 Nov; 19(11):1342-5. PubMed ID: 1003415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hematoporphyrin derivative rescue from toxicity caused by chemotherapy or radiation in a murine leukemia model (L1210).
    Canti G; Franco P; Marelli O; Ricci L; Nicolin A
    Cancer Res; 1984 Apr; 44(4):1551-6. PubMed ID: 6231100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental screening of 3 forms and 19 derivatives or analogs of ellipticine: oncostatic effect on l 1210 leukaemia and immunosuppressive effect of 4 of them.
    Hayat M; Mathé G; Janot MM; Potier P; Dat-Xuong N; Cavé A; Sevenet T; Kan-Fan C; Poisson J; Miet J; Le Men J; Le Goffic F; Gouyette A; Ahond A; Dalton LK; Connors TA
    Biomedicine; 1974 Mar; 21(3):101-6. PubMed ID: 4429763
    [No Abstract]   [Full Text] [Related]  

  • 27. Chemotherapy and immunotherapy of L1210 leukemic mice with antigenic tumor sublines.
    Nicolin A; Canti G; Marelli O; Veronese F; Goldin A
    Cancer Res; 1981 Apr; 41(4):1358-62. PubMed ID: 7011535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bases of antilymphocytic globulin and its therapeutic possibilities].
    Brendel W
    Arzneimittelforschung; 1970 Feb; 20(2):191-7. PubMed ID: 4191782
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemotherapy immunogenicity.
    Goldin A; Nicolin A; Bonmassar E
    Recent Results Cancer Res; 1980; 75():185-94. PubMed ID: 7232831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The enhanced therapeutic effect of cis-platinum (II) diamminodichloride against L1210 leukemia when combined with cyclophosphamide or 1,2-bis(3,5-dioxopiperazine-1-yl)propane or several other antitumor agents.
    Woodman RJ; Sirica AE; Gang M; Kline I; Venditti JM
    Chemotherapy; 1973; 18(3):169-83. PubMed ID: 4119363
    [No Abstract]   [Full Text] [Related]  

  • 31. Antitumor activity of cyclocytidine in a variety of tumors.
    Hoshi A; Kanzawa F; Kuretani K
    Gan; 1972 Jun; 63(3):353-60. PubMed ID: 5072834
    [No Abstract]   [Full Text] [Related]  

  • 32. Characteristics and response to certain cancer chemotherapeutic agents of an acute lymphocytic leukemia arising in a BALB-c times DBA-2F1 mouse.
    Yancey ST; Bleyer WA
    Cancer Res; 1974 Aug; 34(8):1866-9. PubMed ID: 4526157
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of acute leukemia].
    Barry A; Delage JM
    Union Med Can; 1970 Jun; 99(6):1045-54. PubMed ID: 5280031
    [No Abstract]   [Full Text] [Related]  

  • 34. Synergistic effects of bis(3-methylsulfonyloxypropyl)-amine toluenesulfonate (864-T) with 6-mercaptopurine and other antitumor agents.
    Imamura H; Ikegami K; Okumoto T
    Gan; 1973 Oct; 64(5):427-31. PubMed ID: 4358730
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antitumor chemotherapy. Considerations on the potential role of immunity].
    Mihich E
    Pathol Biol; 1967 Feb; 15(3):209-14. PubMed ID: 4860732
    [No Abstract]   [Full Text] [Related]  

  • 36. [Elimination of suppressor macrophages in tumor-bearing mice by 6-mercaptopurine and its therapeutic contribution].
    Kataoka T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):701-5. PubMed ID: 3963841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different aspects of antilymphocyte globulin (ALG) treatment in man.
    Brendel W
    Br J Surg; 1969 Aug; 56(8):621. PubMed ID: 4894619
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunosuppressive treatment in renal homologous transplantation].
    Mazzei D; Vallino F; Civardi F
    Minerva Chir; 1975 Aug 15-31; 30(15-16):866-73. PubMed ID: 772470
    [No Abstract]   [Full Text] [Related]  

  • 39. Radiosensitivity of drug-resistant L1210 leukemia.
    Johnson RE
    Cancer Res; 1967 Feb; 27(2):251-4. PubMed ID: 6018559
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunosuppressive, antiviral and antitumor activities of cytarabine derivatives.
    Gray GD; Nichol FR; Mickelson MM; Camiener GW; Gish DT; Kelly RC; Wechter WJ; Moxley TE; Neil GL
    Biochem Pharmacol; 1972 Feb; 21(4):465-75. PubMed ID: 5014505
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.